| Product Code: ETC6044298 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Algeria Antimicrobial Resistance Market Overview |
3.1 Algeria Country Macro Economic Indicators |
3.2 Algeria Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Algeria Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Algeria Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Algeria Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Algeria Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Algeria Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Algeria Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Algeria Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Algeria |
4.2.2 Rising awareness about the importance of antimicrobial resistance |
4.2.3 Government initiatives to control and prevent antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 Lack of standardized guidelines for antibiotic usage |
4.3.3 High cost associated with antimicrobial resistance treatments |
4.3.4 Presence of counterfeit or substandard antibiotics in the market |
5 Algeria Antimicrobial Resistance Market Trends |
6 Algeria Antimicrobial Resistance Market, By Types |
6.1 Algeria Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Algeria Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Algeria Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Algeria Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Algeria Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Algeria Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Algeria Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Algeria Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Algeria Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Algeria Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Algeria Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Algeria Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Algeria Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Algeria Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Algeria Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Algeria Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Algeria Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Algeria Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Algeria Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Algeria Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Algeria Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Algeria Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Algeria Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Algeria Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Algeria Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Algeria Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Algeria Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Algeria Antimicrobial Resistance Market Export to Major Countries |
7.2 Algeria Antimicrobial Resistance Market Imports from Major Countries |
8 Algeria Antimicrobial Resistance Market Key Performance Indicators |
8.1 Rate of antibiotic prescriptions per capita |
8.2 Percentage of healthcare facilities with antimicrobial stewardship programs |
8.3 Number of reported cases of antibiotic-resistant infections |
8.4 Percentage of healthcare professionals trained in appropriate antibiotic usage |
8.5 Investment in research and development for new antibiotics |
9 Algeria Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Algeria Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Algeria Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Algeria Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Algeria Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Algeria Antimicrobial Resistance Market - Competitive Landscape |
10.1 Algeria Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Algeria Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here